Log In via Athens
Pediatric Only |
Images & Videos Only
Goodman & Gilman's Pharmacologic Basis of Therapeutics, 12e
Section VII. Chemotherapy of Microbial Diseases
Chapter 50. Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections"
Margaret A. Phillips, Samuel L. Stanley, Jr.
Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections: Introduction
parasites; parasitic diseases; pharmacotherapy of infectious diseases; protozoan infections.
Humans host a wide variety of protozoal parasites that can be transmitted by insect vectors, directly from other mammalian reservoirs or from one person to another. Because protozoa multiply rapidly in their hosts and effective vaccines are unavailable, chemotherapy has been the only practical way to both treat infected individuals and reduce transmission. The immune system plays a crucial role in protecting against the pathological consequences of protozoal infections. Thus, opportunistic infections with protozoa are prominent in infants, individuals with cancer, transplant recipients, those receiving immunosuppressive drugs or extensive antibiotic therapy, and persons with advanced human immunodeficiency virus (HIV) infection. Treatment of protozoal infections in immunocompromised individuals is especially difficult, and the outcome is often unsatisfactory...."
The content above is only an excerpt. For full access, log into an existing user account below,
an annual subscription, or
a short-term subscription to the complete website.
Subscriber Log In:
Forgot your Username/Password?
Copyright © McGraw-Hill Global Education Holdings, LLC. All rights reserved.
. Any use is subject to the
Your IP address is 18.104.22.168